What is Hopebridge?
Hopebridge Autism Therapy Centers is a leading provider of early intensive behavioral intervention (EIBI) for children diagnosed with autism spectrum disorder (ASD). Leveraging applied behavior analysis (ABA), the company offers a multidisciplinary approach that includes occupational therapy, speech therapy, and diagnostic assessments. Hopebridge is committed to reducing wait times for evaluations and providing personalized therapy for children aged 15 months to 10 years, with a particular focus on serving underserved communities and ensuring accessibility through insurance collaborations. Their dedication to compassionate, quality care aims to foster significant developmental progress in a supportive environment.
How much funding has Hopebridge raised?
Hopebridge has raised a total of $29M across 5 funding rounds:
Debt
$701K
Private Equity
$1.2M
Private Equity
$1.2M
Private Equity
$3.4M
Private Equity
$22.5M
Debt (2012): $701K, investors not publicly disclosed
Private Equity (2014): $1.2M, investors not publicly disclosed
Private Equity (2015): $1.2M, investors not publicly disclosed
Private Equity (2016): $3.4M, investors not publicly disclosed
Private Equity (2017): $22.5M, investors not publicly disclosed
What's next for Hopebridge?
With substantial enterprise-level backing, Hopebridge is strategically positioned for accelerated expansion and enhanced service delivery. The significant capital infusion is expected to fuel further development of their therapeutic programs, potentially increasing their geographic reach to serve more families in need. Future initiatives may include advancements in diagnostic technologies, further integration of insurance partnerships, and scaling their operational capacity to meet the growing demand for specialized autism services. This investment underscores a strong market confidence in Hopebridge's model and its potential for continued impact in the pediatric behavioral health sector.
See full Hopebridge company page
